New hope for Tough-to-Treat blood pressure in kidney disease patients
NCT ID NCT05460169
First seen May 11, 2026 · Last updated May 12, 2026 · Updated 1 time
Summary
This study tests a procedure called renal denervation, which uses ultrasound to calm overactive nerves in the kidneys, to see if it can safely lower blood pressure in people with autosomal dominant polycystic kidney disease (ADPKD) whose blood pressure remains high despite taking 1-4 medications. About 44 participants will be randomly assigned to receive the procedure immediately or after a delay. The main goal is to measure changes in 24-hour blood pressure three months after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital FAU Erlangen-Nürnberg
Erlangen, 91054, Germany
Conditions
Explore the condition pages connected to this study.